Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Repurchased Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances

Daily Values

Growth Metrics

Genesco (GCO) Change in Accured Expenses (2016 - 2026)

Genesco has reported Change in Accured Expenses over the past 17 years, most recently at $17.8 million for Q1 2026.

For Q1 2026, Change in Accured Expenses rose 196.33% year-over-year to $17.8 million; the TTM value through Jan 2026 reached $9.4 million, down 21.8%, while the annual FY2026 figure was $9.4 million, 21.8% down from the prior year.
Change in Accured Expenses for Q1 2026 was $17.8 million at Genesco, up from -$2.9 million in the prior quarter.
Over five years, Change in Accured Expenses peaked at $17.8 million in Q1 2026 and troughed at -$44.2 million in Q2 2022.
A 5-year average of -$1.9 million and a median of -$2.4 million in 2023 define the central range for Change in Accured Expenses.
On a YoY basis, Change in Accured Expenses climbed as much as 316.84% in 2025 and fell as far as 603.71% in 2025.
Year by year, Change in Accured Expenses stood at $1.4 million in 2022, then tumbled by 264.68% to -$2.4 million in 2023, then decreased by 25.36% to -$3.0 million in 2024, then rose by 1.81% to -$2.9 million in 2025, then surged by 708.95% to $17.8 million in 2026.
Business Quant data shows Change in Accured Expenses for GCO at $17.8 million in Q1 2026, -$2.9 million in Q4 2025, and $9.7 million in Q3 2025.